USPH Q2 revenue up 8.5% to $143.5M; EPS $0.47 vs $0.64; guidance reaffirmed at $80-85M EBITDA

U S PHYSICAL THERAPY INC /NV

2024-Q2 EPS reported $0.93 revenue$322,865,000

GAAP net income $7.5M ($0.47 diluted EPS) vs $10.9M ($0.64) in Q2 2023; share count up from May 2023 secondary offering.
Adjusted EBITDA $22.1M vs $21.7M; non-GAAP Operating Results $0.73/share vs $0.76.
Total patient visits hit all-time quarterly high of 1,335,335, up 5.4%; net rate per visit $105.05 (+3.0%).
Industrial injury prevention revenue up 23.2% to $23.7M; acquired an IIP business for $24M on April 30, 2024.
Quarterly dividend $0.44/share declared (payable Sep 13, record Aug 23); clinic count 681 vs 656 a year ago.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.